ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

RANI Rani Therapeutics Holdings Inc

7.15
0.00 (0.00%)
プレマーケット
最終更新日: 20:08:27
15分遅延
名称 銘柄コード 市場 種別
Rani Therapeutics Holdings Inc RANI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 7.15 20:08:27
始値 安値 高値 終値 前日終値
7.15
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2105:05GLOBERani Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/3/1605:05GLOBERani Therapeutics to Report Fourth Quarter and Full Year..
2024/2/0522:10EDGAR2Form 8-K - Current report
2024/2/0522:00GLOBERani Therapeutics Announces Positive Topline Results from..
2023/12/2006:06EDGAR2Form 8-K - Current report
2023/12/2006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1422:05EDGAR2Form 8-K - Current report
2023/12/1422:00GLOBERani Therapeutics Announces Preclinical Pharmacodynamic Data..
2023/12/0807:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0622:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0122:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0906:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:10EDGAR2Form 8-K - Current report
2023/11/0906:05GLOBERani Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0205:05GLOBERani Therapeutics Announces Strategic Program..
2023/11/0205:04EDGAR2Form 8-K - Current report
2023/10/2521:03EDGAR2Form 8-K - Current report
2023/10/2521:00GLOBEThe RaniPill® Capsule, Rani Therapeutics’ Oral Delivery..
2023/10/2005:05GLOBERani Therapeutics Announces Successful Oral Delivery of..
2023/10/1305:05GLOBERani Therapeutics to Present Abstract on RT-102 at the 2023..
2023/9/1821:00GLOBERani Therapeutics Initiates Phase 1 Study of RT-111..
2023/9/0806:04EDGAR2Form 8-K - Current report
2023/9/0805:05GLOBERani Therapeutics Announces Successful Drug Delivery of..
2023/9/0621:00GLOBERani Therapeutics to Participate in September Investor..
2023/8/1205:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1205:05GLOBERani Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0905:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0905:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/0505:05GLOBERani Therapeutics to Participate in August Investor..
2023/6/2121:00GLOBERani Therapeutics’ Presentation On Oral Delivery of PTH for..
2023/6/0821:00GLOBERani Therapeutics Announces Acceptance of Late-Breaking..
2023/6/0521:00GLOBERani Therapeutics and Celltrion Expand Partnership to..
2023/6/0121:00GLOBERani Therapeutics to Present at the Jefferies Healthcare..
2023/5/3121:00GLOBERani Therapeutics Announces Acceptance of Three Abstracts..
2023/5/2421:00GLOBERani Therapeutics Appoints Kate McKinley as Chief Business..
2023/5/1105:05GLOBERani Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock